Macrogenics (MGNX) Change in Receivables (2012 - 2026)
Macrogenics' (MGNX) quarterly Change in Receivables came in at -$2.9 million in Q1 2026, down 147.28% year-on-year from $6.2 million in Q1 2025, and up 94.72% on a QoQ basis from -$55.9 million in Q4 2025.
Macrogenics (MGNX) Change in Receivables (2012 - 2026) Analysis & Trends
Macrogenics (MGNX) has 15 years of Change in Receivables data on file, last reported at -$2.9 million in Q1 2026.
- On a quarterly basis, Change in Receivables fell 147.28% year-over-year to -$2.9 million in Q1 2026; TTM through Mar 2026 was -$117000.0, a 103.52% decrease from a year earlier, with the FY2025 full-year figure at $9.1 million, up 249.6% from the prior year.
- Change in Receivables for Q1 2026 stood at -$2.9 million, up from -$55.9 million in the prior quarter.
- Over the last five years, Change in Receivables for MGNX reached as high as $56.7 million in Q3 2025 and fell as low as -$55.9 million in Q4 2025.
- Historically, Change in Receivables has averaged $2294.1 across 5 years, with a median of -$1.0 million in 2024.
- On a YoY basis, Change in Receivables climbed as much as 2114.77% in 2025 and fell as far as 1157.5% in 2025.
- Year by year, Change in Receivables stood at $42.4 million in 2022, then slumped by 135.26% to -$14.9 million in 2023, then soared by 70.28% to -$4.4 million in 2024, then slumped by 1157.5% to -$55.9 million in 2025, then surged by 94.72% to -$2.9 million in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were -$2.9 million in Q1 2026, -$55.9 million in Q4 2025, and $56.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Macrogenics | 254.43 Mn | 187.92 Mn | - | -2.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.95 Mn |
| Mar 31, 2026 | -2.95 Mn |
| Dec 31, 2025 | -55.86 Mn |
| Dec 31, 2025 | -55.86 Mn |
| Sep 30, 2025 | 56.70 Mn |
| Sep 30, 2025 | 56.70 Mn |
| Jun 30, 2025 | 1.99 Mn |
| Jun 30, 2025 | 1.99 Mn |
| Mar 31, 2025 | 6.23 Mn |
| Mar 31, 2025 | 6.23 Mn |
| Dec 31, 2024 | -4.44 Mn |
| Dec 31, 2024 | -4.44 Mn |
| Sep 30, 2024 | 2.56 Mn |
| Sep 30, 2024 | 2.56 Mn |
| Jun 30, 2024 | -1.03 Mn |
| Jun 30, 2024 | -1.03 Mn |
| Mar 31, 2024 | -3.15 Mn |
| Mar 31, 2024 | -3.15 Mn |
| Dec 31, 2023 | -14.94 Mn |
| Dec 31, 2023 | -14.94 Mn |